IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today ...
InMode ( (INMD)) has issued an announcement. On February 2, 2026, InMode issued a statement responding to market speculation surrounding a publicly announced non-binding proposal from Steel Partners ...
InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, ...
InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
Stocktwits on MSN
INMD stock jumped nearly 13% today – what’s powering the rally?
The company went public in 2019 at a post-money valuation of $480 million, according to the report. ・InMode has been facing ...
As of April 24, 2023, the average one-year price target for Inmode is 47.53. The forecasts range from a low of 40.40 to a high of $55.65. The average price target represents an increase of 41.00% from ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results